SELLAS Life Sciences Enters $21M Securities Purchase Agreement With Institutional Investor; Direct Offering Includes 15.8M Shares And Warrants Priced At $1.325 Per Share, Exercisable At $1.20; Expected To Close On August 1, 2024
SELLAS Life Sciences Enters $21M Securities Purchase Agreement With Institutional Investor; Direct Offering Includes 15.8M Shares And Warrants Priced At $1.325 Per Share, Exercisable At $1.20; Expected To Close On August 1, 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.